|Bid||47.13 x 1100|
|Ask||47.79 x 900|
|Day's range||47.04 - 49.95|
|52-week range||28.50 - 99.27|
|Beta (5Y monthly)||1.67|
|PE ratio (TTM)||27.22|
|Earnings date||10 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||95.00|
The consumer healthcare market is a multi-trillion dollar industry worldwide that could double by 2028, according to Verified Market Research, which means there are opportunities to be had for patient investors. The company recently reported third-quarter 2021 results that showcased a 31% year-over-year increase in monthly active users and a 68% increase in subscription plans.
InMode Ltd. (INMD) stock has fallen, losing -23.3% this year. The specialty medical device maker pulled back with the weakness in growth stocks. But another likely reason is Big Money dropping the stock.
Shares of medical company InMode (NASDAQ: INMD) were up 197.3% in 2021, according to data provided by S&P Global Market Intelligence. InMode makes medical devices that emit radio frequencies, a minimally and (in some cases) non-invasive way to perform types of plastic surgery and skin care, among other things. In 2020, InMode generated record revenue of $206 million, which was up 32% from 2019 despite challenges from the COVID-19 pandemic.